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Abstract
Background
Chronic kidney disease (CKD) is a probably underrated public health problem in Sub-Saha-
ran-Africa, in particular in combination with HIV-infection. Knowledge about the CKD preva-
lence is scarce and in the available literature different methods to classify CKD are used
impeding comparison and general prevalence estimates.
Methods
This study assessed different serum-creatinine based equations for glomerular filtration
rates (eGFR) and compared them to a cystatin C based equation. The study was conducted
in Lilongwe, Malawi enrolling a population of 363 adults of which 32% were HIV-positive.
Results
Comparison of formulae based on Bland-Altman-plots and accuracy revealed best perfor-
mance for the CKD-EPI equation without the correction factor for black Americans. Analyz-
ing the differences between HIV-positive and –negative individuals CKD-EPI systematically
overestimated eGFR in comparison to cystatin C and therefore lead to underestimation of
CKD in HIV-positives.
Conclusions
Our findings underline the importance for standardization of eGFR calculation in a Sub-
Saharan African setting, to further investigate the differences with regard to HIV status and
to develop potential correction factors as established for age and sex.
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Introduction
Chronic kidney disease (CKD) constitutes a leading cause of morbidity and mortality in high
income countries and is increasingly recognized as important for low and middle income coun-
tries (LMICs). [1,2] The impact in LMICs is aggravated by the combination of increasing non-
communicable diseases (NCDs) with the continuing burden of infectious diseases and limited
access to health care services. [3–5] However, knowledge about the prevalence of CKD in sub-
Saharan-Africa (SSA) still remains limited. Reliable data sources on morbidity and mortality
such as death registers are not available. [6,7] Estimates suggest about 200–300 per million peo-
ple are living with CKD in SSA. [8]
The few published studies show a large variation of CKD prevalence ranging from 4.7% in
HIV-negatives in Uganda [9] up to 33.5% in HIV-positives in Zambia. [10] When defining
CKD by proteinuria or eGFR<60ml/min/1.73 m², a recently published systematic review
reported an average prevalence of CKD in SSA of 13.9%. [11] A study conducted in Kinshasa,
DRC, found 12.4% prevalence of CKD estimated by the MDRD-equation. Hypertension and
age were independently associated with CKD stage 3 and hypertension also with proteinuria.
[12] As HIV still constitutes a major public health problem in SSA and can itself cause
nephropathy, there is more data about CKD in HIV-positive than HIV-negative individuals.
[13–15] Reported large variations in prevalence of CKD in SSA may result from different
thresholds used for the definition of CKD, differences in study design, or non-comparability of
the equations and laboratory methods applied to estimate renal function. [16]
The increasing relevance of chronic non-communicable diseases in regions like SSA empha-
sizes the need to establish appropriate and well validated methods to assess renal function.
Guidelines developed by the American Kidney Foundation promote the use of creatinine based
equations to estimate the glomerular filtration rate (GFR), [17] such as the Cockcroft-Gault-
formula, [18] and the MDRD-4, [19] and in 2012, the Kidney Diseases Improving Global Out-
comes (KDIGO) organization [20] recommended the use of the CKD-EPI-formula. [21] Creat-
inine-based equations are preferred as the serum creatinine determination is a simple, non-
expensive, internationally standardized test. [22] Nonetheless, these equations have originally
been developed and evaluated in Northern American patient cohorts with mild CKD and
therefore might not simply be applicable to SSA cohorts. [21]
Serum creatinine depends on various factors such as sex, age, muscle mass, nutrition and
physical activity, [21] some of which are linked to socioeconomic status. Therefore, a noncriti-
cal application of these formulae in low and middle income countries appears questionable.
Levey et al. found significant differences in the serum creatinine levels of self-defined white
and black Americans, which were not related to the measured eGFR. Hence, to adjust the
eGFR for these differences in serum creatinine, Levey et al. established a correction factor for
black Americans for the MDRD and CKD-EPI GFR estimation formulas. [19,21] However, the
differences attributed to “black American” could be confounded by the socioeconomic class
factors in the US or epi-genetic adaptations due to the history of slavery in the US. [23–25] A
study conducted in Ghana showed that GFR calculated from 24 hour urine collection was best
comparable to eGFR either by MDRD-4 or CKD-EPI omitting the factor for black Americans.
[26] In many studies previously conducted in SSA it is not evident whether this factor, which is
often incorrectly referred to as a correction factor for black skin colour, was applied or not.
Another approach to estimate kidney function is using cystatin C based equations. Cystatin
C is produced at a relatively constant rate, and is not significantly influenced by inflammatory
processes. [27] Cystatin C depends less on body characteristics such as muscle mass and is sug-
gested to better estimate the GFR compared to serum creatinine based equations, even in HIV
positives. Various studies show a stronger correlation of gold-standard GFR and serum cystatin
Evaluation of Different eGFR Formulae in a Malawian Cohort
PLOS ONE | DOI:10.1371/journal.pone.0130453 June 17, 2015 2 / 17
their adherence to PLOS ONE policies on sharing
data and materials.
C estimated GFR compared to serum creatinine estimated GFR, especially in HIV-positives.
[28,29] Nevertheless in the foreseeable future Cystatin C estimates will not be available in most
of the SSA laboratories. Reliable estimates of CKD prevalence in SSA regions in order to guide
treatment and prevention strategies will require the development of a standardized, possibly
creatinine-based GFR-estimation formula. We used data of HIV-positive adults not on antire-
troviral treatment and HIV-negative adults as part of a study at a HIV-testing centre in central
Malawi to validate the performance of various creatinine-based estimating equations of GFR in
comparison to a cystatin C formula.
Methods
Study design and study population
Between the 24th of January 2012 and the 29th of March 2012 a cross-sectional survey was
conducted to analyse the prevalence of renal impairment in the study population and to assess
and compare the diagnostic validity of the different GFR estimation formulae. All individuals
over 18 years of age and ART-naïve, coming to the HIV counselling and testing centre at the
Lighthouse Clinic in Lilongwe, Malawi were invited to participate in the study. No other
exclusion criteria applied. This large HIV clinic serves a mainly urban catchment population of
altogether 1,9 million people. [30] Following informed consent, a standardized questionnaire
about age, gender, possible pregnancy, current symptoms, medical and family history was
administered. Body height and weight were taken in a standardized way and blood pressure
was measured using the same calibrated standard automatic blood pressure device (Omron,
Germany) on the free right arm at heart level after at least 10 minutes of sitting with the back at
the backrest of the chair.
Laboratory measurements
Assessment of renal function. Following venous blood draw and centrifugation an aliquot
of serum was frozen at -80° Celsius and shipped to Germany (dry ice). Serum creatinine and
cystatin C were analysed at University of Heidelberg. Serum creatinine was determined with a
photometric measurement and traceable to an isotope dilution mass spectrometry (IDMS) ref-
erence measurement procedure, [22] according to standards. Cystatin C was determined by a
turbidimetric method (ADVIA 2400 Siemens Healthcare Diagnostics). Laboratory staff was
blinded for underlying diseases, HIV status and patient background.
We used cystatin C as a reference to detect a serum creatinine based equation closest to
cystatin C to allow reliable future creatinine based GFR estimation in resource limited settings.
Creatinine-based eGFR was calculated using the Cockcroft-Gault, [18] the MDRD-4 [19,31]
and the CKD-EPI [21] equations. Cystatin C based eGFR was calculated using the formula by
van Deventer et al. [32] developed in a comparable cohort in South Africa and verified by the
CKD-EPI equations for cystatin C. [33] Table 1 gives lists all formulae used. The accordance of
the GFR estimated by creatinine formulae with the cystatin C based values was checked using
Bland-Altman-Plots.
In a first step we compared each creatinine based eGFR to the eGFR derived from cystatin C
(formula according to van Deventer), and their performance regarding HIV status. In a second
step we compared the performance of the creatinine based eGFR formulae among each other,
with and without considering the factor for black Americans.
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Statistical analysis
Data analysis was done in STATA 10 and SAS 9.3. Significance in the differences between
HIV-positive and—negative cohorts were tested using appropriate tests according to the
underlying distribution. Agreement between different measurement techniques was assessed
by Bland-Altman-Plots. [34–36] Bland-Altman graphs were created by plotting the means (x-
axes) of two GFR estimation methods against their differences (y-axes). We applied linear
regression models to obtain the mean differences and the limits of agreement in presence of
heteroscedasticity, as suggested in [35]. In presence of strong non-linearity and differences in
the distribution shapes we used quantile regression. [37–39] Plots were grouped according to
HIV status. In case of visible differences between HIV- negatives and-positives the mean dif-
ferences and the limits of agreement were presented separately. Additional analyses were per-
formed to assess the formulae by calculating the absolute and relative bias, the precision, and
the accuracy. Firstly, to determine the central distance between two formulae we calculated
the overall mean differences (absolute bias) between the estimated GFRs to be compared.
The reference eGFR was interpreted to be overestimated by the predicting eGFR if values
were< 0, and underestimated if values were> 0. Secondly, we calculated the precision, which
is the standard error of the mean differences. Thirdly, we calculated the relative bias which is
the division of the mean differences between the two estimates by the reference eGFR value.
Fourthly, accuracy between two methods was shown by the proportion of values obtained
with method A of those estimated by method B within a margin of 10%, and 30% respectively.
Finally we assessed the resulting differences in staging of patients to a level of CKD when
applying different formulae.
Table 1. Evaluations used for estimation of GFR.
Creatinine-based equations:
Cockcroft-Gault: [18] eGFR = (140-age) x mass [in kg] x 0.85 [if female] / 72 x SCr
MDRD-4: [31] eGFR = 175 x SCr-1.154 x age-0.203 x 1.212 [if black] x 0.742 [if female]
CKD-EPI: [21]
Black American
Female 0.7 mg/dL: eGFR = 166 x (SCr/0.7)-0.329 x (0.993)age
>0.7 mg/dL: eGFR = 166 x (SCr/0.7) -1.209 x (0.993)age
Male 0.9 mg/dL: eGFR = 163 x (SCr/0.9) -0.411 x (0.993)age
>0.9 mg/dL: eGFR = 163 x (SCr/0.9) -1.209 x (0.993)age
White or other
Female 0.7 mg/dL: eGFR = 144 x (SCr/0.7) -0.329 x (0.993)age
>0.7 mg/dL: eGFR = 144 x (SCr/0.7) -1.209 x (0.993)age
Male 0.9 mg/dL: eGFR = 141 x (SCr/0.9) -0.411 x (0.993)age
>0.9 mg/dL: eGFR = 141 x (SCr/0.9) -1.209 x (0.993)age
Cystatin C based equations:
Van Deventer: [32] eGFR = 102.35 x 10(SCysC [mg/L] x -0.33) x 10(-0.003 x age)
CKD-EPI: [33]
Without correction factors: eGFR = 76.7 x SCysC-1.19
With correction factors: eGFR = 127.7 x SCysC-1.17 x age-0.13 x 0.91 [if female] x 1.06 [if black]
Creatinine was measured in mg/dl and IDMS traceable, cystatin C was measured by a turbidimetric method
in mg/l; weight measured in kg, age measured in years. Abbreviations: SCr = serum creatinine,
SCysC = serum cystatin C
doi:10.1371/journal.pone.0130453.t001
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Ethics Statement
Participants provided consent in written form or by fingerprint. The study protocol and the
consent procedure received ethical clearance by the ethical committee of Heidelberg University
and the National Health Sciences Research Committee of Malawi.
Results
Out of 381 clients approached to participate in the study, 366 consented (95%) and data from
363 participants (48% female) were included in the final analysis. Reasons for the exclusion of
three participants were previous ART and two missing samples.
116 (32%) participants were HIV-positive and 247 were HIV-negative (68%) (details see
Table 2). Mean BMI between HIV-positives and-negatives differed significantly. Three had
previously been diagnosed with kidney disease: two could not specify the disease, the other one
reported glomerulonephritis.
The performance of the various GFR estimation formulae was assessed by comparing the
different creatinine based equations with the cystatin C based equation by van Deventer et al.
[32] in Bland Altman plots. [40]
Figs 1–3 present the comparisons of the different creatinine equations with the cystatin C
equation (van Deventer) without the correction factor for black Americans. All comparisons
show an increasing agreement with increasing mean eGFR for HIV negatives (narrowing limits
of agreement). All comparisons show differences with respect to HIV status; hence, the creati-
nine based eGFR of HIV positives seems to be higher in general. For cystatin C vs. CKD-EPI,
the mean differences regression line remains closest to zero over the entire range for HIV-nega-
tives, indicating almost no trend in the bias, while for cystatin C vs. MDRD-4 and cystatin C
vs. Cockcroft-Gault, the course of the regression line has a strong tendency. The Cockcroft-
Gault formula shows the smallest mean differences between HIV-positives and-negatives, most
likely because it controls for body weight. Altogether, cystatin C vs. CKD-EPI is least biased for
both HIV negatives and positives and has the tightest limits of agreement. A sensitivity analysis
Table 2. Characteristics of included individuals.
Overall: Median (IQR) or n (% of
total)





Age 31 (26–39) 32 (27–37.5) 31 (25–41) 0.81a
Sex women 174 (48%) 57 (49%) 117 (47%) 0.75b
men 189 (52%) 59 (51%) 130 (53%)





15 (4%) 0 (0%) 16 (6.5%) 0.005b
newly diagnosed 1 (0.03%)
History of tuberculosis 17 (5%) 6 (5%) 11 (4%) 0.835b
History of kidney disease in the past 3 (1%) 0 (0%) 3 (1%) 0.565b
BP > 140 systolic or > 90 diastolic 49 (14%) 9 (8%) 40 (16%) 0.028b
Serum creatinine 0.73 mg/dl (0.63–0.85) 0.69 mg/dl (0.59–0.83) 0.74 mg/dl (0.64–0.85) 0.21a
Serum cystatin C 0.78 mg/l (0.7–0.89) 0.87 mg/l (0.78–0.98) 0.75 mg/l (0.67–0.84) <0.001a
CKD stage 3+ CKD-EPI 7 (1.9%) 2 (1.7%) 5 (2.0%) 0.85b
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using the cystatin C based equation evaluated by CKD-EPI showed similar results as the Cysta-
tin C formula by Deventer et al., CKD-EPI creatinine still performed best compared to Cock-
croft-Gault and MDRD-4 (see supplementary figures in S1, S2, S3, S4, S5, and S6 Figs).
However, the variation was increased in general.
Directly comparing the CKD-EPI and the MDRD-4 formula without the factor for black
Americans shows completely different performance at higher mean eGFR, although values at
lower levels are rather similar. Further, a difference between HIV-positives and-negatives can-
not be recognised here (Fig 4).
Applying the factor for black Americans in the creatinine based formulae yielded a similar
distribution pattern compared to the plot of CKD-EPI without the factor for black Americans,
but witha stronger bias tendency. For MDRD-4 with factor for black Americans the mean also
Fig 1. Cystatin C (van Deventer) vs. Cockcroft-Gault. The coloured lines represent the mean differences
of the two equations to be compared at every point of the mean of the estimated GFRs, by HIV status; the
coloured shaded areas mark the limits of agreement, which are mean- differences plus or minus two
standard-deviations. Assuming a normal distribution, 95% of the dots are expected to appear within the limits
of agreement. [40] Closer margins reflect a higher agreement of the different methods.
doi:10.1371/journal.pone.0130453.g001
Fig 2. Cystatin C (van Deventer) vs. MDRD-4 (without factor for black Americans).
doi:10.1371/journal.pone.0130453.g002
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shifted towards lower values, mostly< 0, compared to MDRD-4 without this adjustment factor
(Figs 5 and 6).
To explore whether the difference between formulae with and without factor for black
Americans was confounded by the cystatin C equation calculated by van Deventer et al. in
black South-Africans, we compared CKD-EPI with and without the factor with the CKD-EPI
cystatin C equation by Stevens et al., which has been developed based on results of different
pooled cohorts with GFR measured by iothalamate. [20,33] Both figures show similar distribu-
tion pattern, with mean differences shifted towards lower numbers for both HIV-negatives
and-positives in case the factor is considered (see Figs 7 and 8).
By numerical assessment CKD-EPI, Cockcroft-Gault and MDRD-4 showed a similar overall
absolute bias with a larger bias for HIV-positives (Table 3). Comparing Cockcroft-Gault with
MDRD-4 or CKD-EPI, respectively, the overall bias was small but of different direction in
HIV-positives and-negatives. Comparing against formulae with factor for black Americans
yielded the worst bias.
Fig 3. Cystatin C (van Deventer) vs. CKD-EPI (without factor for black Americans).
doi:10.1371/journal.pone.0130453.g003
Fig 4. MDRD-4 (without factor for black Americans) vs. CKD-EPI (without factor for black Americans).
doi:10.1371/journal.pone.0130453.g004
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Referencing to cystatin C, the precision (standard error of the mean) showed best results for
CKD-EPI (see Table 3); higher values for MDRD-4 and Cockcroft-Gault indicate greater vari-
ability of those methods in comparison to cystatin C, even though the absolute bias slightly
differs. The magnitude of the relative bias was always close to the absolute bias. The supple-
mentary table in S1 Table shows the results when referencing to one of the CKD-EPI cystatin C
equations. Again, CKD-EPI shows the lowest variability.
We counted all GFR values obtained with formula A lying within a range of plus/minus
30% of the corresponding value of formula B. Accuracy with reference to cystatin C was highest
for CKD-EPI (Table 4). However, differences between the HIV groups of HIV-negative and-
positive were large. Best of all performed MDRD-4 versus CKD-EPI. Applying the factor for
black Americans resulted in lower accuracy. Limiting the agreement range to 10% drastically
decreased accuracy (see Table 4 and supplementary material in S2 Table).
The resulting differences in classification agreement of CKD stages when comparing two
formulae are shown in Table 5 (see additional material in S3 Table), using stage 3 respectively
Fig 5. Cystatin C (van Deventer) versus MDRD4 with factor for black Americans.
doi:10.1371/journal.pone.0130453.g005
Fig 6. Cystatin C (van Deventer) versus CKD-EPI with factor for black Americans.
doi:10.1371/journal.pone.0130453.g006
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stage 2 as cut off. Regarding stage 3 and above, creatinine based CKD-EPI yields a prevalence
of 1.9% (7 cases; not visible in the table), and cystatin C (van Deventer) of 3% (11 cases), for
instance. However, altogether 8 cases were classified differentially by both methods. With CKD
stage 2 as cut off, CKD-EPI yields a prevalence of 9.6% (35 cases; not visible in the table), and
cystatin C a prevalence of 27.8% (101 cases), with around 20% of the persons classified stage 2
or higher by cystatin C but not by CKD-EPI at the same time.
Discussion
In this study we validate different creatinine based equations for GFR in 363 Malawian adults,
comprising HIV-negative and-positive individuals, in comparison with the cystatin C based
equation (van Deventer). It further highlights the eGFR differences in HIV-positive and-nega-
tive individuals in a SSA-country and scrutinizes the use of a correction factor designed for
black Americans. The CKD-EPI creatinine based formula turned out to currently best assess
eGFR in our setting, although the obtained CKD classification results still entail uncertainties.
Fig 7. CKD-EPI-Cystatin-C versus CKD-EPI with factor for black Americans.
doi:10.1371/journal.pone.0130453.g007
Fig 8. CKD-EPI-Cystatin-C versus CKD-EPI without factor for black Americans.
doi:10.1371/journal.pone.0130453.g008
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When referencing to any CKD-EPI cystatin C equation in a sensitivity analysis, CKD-EPI cre-
atinine also performed best. The validation showed considerable differences in performance/
accuracy of the equations depending on the HIV status. In HIV-positives CKD-EPI eGFR val-
ues are systematically overestimated in relation to cystatin C. Introducing the adjustment fac-
tor for black Americans in the creatinine based formulae further overestimates GFR. Despite
some remaining uncertainties, we therefore recommend using the creatinine based CKD-EPI
formula without the factor for black Americans, in SSA contexts. Further research should
investigate the reasons behind the differences in HIV-negatives and-positives and identify
adjustment variables such as BMI.
With regard to HIV-positive individuals the importance of renal dysfunction and HIV
related morbidity and mortality has been highlighted in the EuroSIDA cohort and will become
increasingly important for HIV patients in Africa, where renal impairment is not routinely
diagnosed. [41]
GFR estimation is essential to assess the burden of CKD in a population. Data from Malawi
itself is scarce: There is only one study with 526 ART-naïve HIV-positives using the Cockcroft-
Gault-formula to investigate severe renal impairment. [42] In contrast, our study for the first
time systematically assesses the performance of different eGFR formulae and also includes a
group of HIV-negative Malawian adults, even though it may not be a representative sample of
the general adult Malawian population.
Table 3. Absolute bias (mean differences) and precision (standard error of the mean differences), and relative bias of two formulas to be
compared.
absolute bias (precision), relative bias Overall (N = 363) HIV- (N = 247) HIV+ (N = 116)
Cystatin C vs. CKD-EPI -17.0 (0.7), 17.6% -13.7 (0.8), 13.8% -24.1 (1.1), 26.5%
Cystatin C vs. MDRD4 -14.3 (1.2), 14.8% -10.1 (1.4), 10.3% -23.1 (2.1), 25.5%
Cystatin C vs. Cockcroft-Gault -18.7 (1.3), 19.4% -18.4 (1.7), 18.6% -19.4 (2.1), 21.4%
Cystatin C vs. CKD-EPI modified* -34.5 (0.8), 35.8% -31.1 (0.9), 31.4% -41.8 (1.3), 46.0%
Cystatin C vs. MDRD4 modified* -37.5 (1.5), 39.0% -33.1 (1.7), 33.4% -47.1 (2.6), 51.8%
CKD-EPI cystatin Ca vs. CKD-EPI modified* -28.1 (1.1), 27.3% -22.0 (1.3), 20.3% -41.3 (1.6), 45.2%
CKD-EPI cystatin Ca vs. CKD-EPI -10.6 (1.1), 10.3% -4.5 (1.3), 4.2% -23.5 (1.5), 25.7%
Cockcroft-Gault vs. MDRD4 4.4 (1.3), -3.8% 8.2 (1.6), -7.0% -3.7 (2.0), -3.4%
Cockcroft-Gault vs. CKD-EPI 1.7 (1.2), -1.5% 4.7 (1.5), -4.0% -4.6 (1.8), 4.2%
MDRD4 vs. CKD-EPI -2.7 (0.7), 2.4% -3.5 (0.9), 3.2% -0.9 (1.3), 0.8%
* with factor for black Americans
a CKD-EPI equation: eGFR = 76.7 x CystC-1.19
doi:10.1371/journal.pone.0130453.t003
Table 4. 30% and 10% accuracy.
30% accuracy 10% accuracy
%of estimates A within %range of B all HIV- HIV+ all HIV- HIV+
CKD-EPI vs. cystatin C 81% 92% 59% 24% 29% 12%
MDRD4 vs. cystatin C 76% 83% 60% 33% 38% 22%
Cockcroft-Gault vs. cystatin C 69% 69% 71% 28% 31% 21%
MDRD4 vs. CKD-EPI 99% 99% 99% 51% 49% 53%
Cystatin C vs. CKD-EPI modified* 67% 78% 43% 6% 8% 2%
* with factor for black Americans
doi:10.1371/journal.pone.0130453.t004
Evaluation of Different eGFR Formulae in a Malawian Cohort
PLOS ONE | DOI:10.1371/journal.pone.0130453 June 17, 2015 10 / 17
Comparison of creatinine based equations to cystatin C estimated GFR
The CKD-EPI-formula showed the best performance at all levels of eGFR compared to the
cystatin C (van Deventer) reference values in HIV-negatives, with acceptable limits of agree-
ment, and almost no tendency regarding the bias of the mean differences of the eGFRs. How-
ever, differences in the bias result in different CKD stage classifications, which is especially
important in the transition from CKD stage 2 to 3. Considering mean eGFR values lower 60,
which corresponds to CKD stage 3 and higher, MDRD-4 and Cockcroft-Gault visually seem to
overestimate CKD in comparison to cystatin C, whereas at higher eGFR both formulae under-
estimate CKD. This is consistent with the discrepant classification results for CKD stage 2 and
higher. These results concur with studies that found the CKD-EPI equation more accurate
than the MDRD-4-equation overall and across most subgroups especially in eGFR-levels> 60
ml/min/1.73m². [43,44]
The overall absolute bias of CKD-EPI versus cystatin C was similar compared to MDRD-4.
However, the absolute bias is only an overall measure, not considering any trends or differences
in various eGFR categories and levels. CKD-EPI precision against cystatin C was closest to
zero, compared to MDRD-4 and Cockcroft-Gault and therefore suggesting a better fit. In
addition, 30% accuracy of CKD-EPI to Cystatin C was relatively high for HIV-negatives. In
summary, although established in a cohort living in a high-income country with different con-
ditions of life, and a low prevalence of impaired renal function, the creatinine based CKD-EPI
formula seems to yield results closest to the assumed GFR values, represented here by cystatin
C (van Deventer). The fact that the level of agreement remained similar between CKD-EPI and
a second cystatin C formula (CKD-EPI cystatin C) underpins the statement that the creatinine
based CKD-EPI formula without the factor for black Americans is a useful initial marker to
estimate GFR in HIV-negatives, as suggested by others. [26,45]
The clinically relevant classification into CKD stages 3 differs, depending on which for-
mula is applied, but only in a few cases as the overall number of CKD cases was small. Hence,
the same calculation was repeated with stage 2 as cut off point. Here, cystatin C is stricter in
classifying CKD stages, compared to the others, which is in line with the on average higher
eGFR values achieved by CKD-EPI. Following the Bland-Altman plots, it can be assumed, that
a large portion of cases classified as CKD by cystatin C but not by CKD-EPI are HIV positives.
Table 5. Discrepancies in staging results, cut off stage 3 and 2.
Discrepant results CKD stage 3 A versus
B
Same CKD stages splitting  3 and < 3
(%)
CKD stage  3: A, not B
(%)
CKD stage  3: B, not A
(%)
CKD-EPI vs. cystatin C 355 (97.8) 6 (1.7) 2 (5.5)
MDRD4 vs. cystatin C 354 (97.5) 4 (1.1) 5 (1.4)
Cockcroft-Gault vs. cystatin C 355 (97.8) 4 (1.1) 4 (1.1)
CKD-EPI modified* vs. cystatin C 355 (97.8) 1 (0.3) 7 (1.9)
Discrepant results CKD stage 2 A versus
B
Same CKD stages splitting  2 and < 2
(%)
CKD stage  2: A, not B
(%)
CKD stage  2: B, not A
(%)
CKD-EPI vs cystatin C 285 (78.5) 6 (1.7) 72 (19.8)
MDRD4 vs cystatin C 285 (78.5) 23 (6.3) 55 (15.2)
Cockcroft-Gault vs cystatin C 281 (77.4) 22 (6.1) 60 (16.5)
CKD-EPI modified* vs. cystatin C 279 (76.9) 1 (0.3) 83 (22.)
* with factor for black Americans
doi:10.1371/journal.pone.0130453.t005
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The results of other studies which showed that the CKD-EPI equation classified fewer indi-
viduals having CKD and better categorized mortality-risks and end stage renal disease (ESRD)
probability than the MDRD-equation back these findings. [46]
Different performances in GFR estimation regarding HIV status
In our study the distribution of age and sex were comparable between HIV-positives and nega-
tives and therefore age should not influence any differences between the groups. However,
there was a significant and expected difference in BMI between HIV positive and HIV negative
participants. For CKD-EPI the mean differences regression line of HIV-positives is always
below zero, indicating constant overestimation of creatinine based eGFR. For all other equa-
tions the mean differences regression lines depend on the level of eGFR. However, the smallest
distance between the mean differences regression lines of the HIV-positives and-negatives is
observable between cystatin C based equations and Cockcroft-Gault. This finding results most
likely on the one hand from cystatin C being almost independent of body weight and on the
other hand from the fact that Cockcroft-Gault is the only creatinine based formula considering
body weight, and weight was significantly different between HIV-positives and-negatives. This
is further supported by median serum creatinine and cystatin C. Serum creatinine was lower in
HIV-positives compared to-negatives, which is consistent with lower BMI, but median serum
cystatin C was significantly higher in HIV-positives. Therefore, cystatin C seems to indicate a
real difference between HIV-positives and-negatives, independent of BMI, therefore directly
describing differences in kidney function. In consequence, applying creatinine based eGFR for-
mulae in HIV-positives without adjusting for BMI (or other related confounders) tends to
overestimate GFR and as a result underestimate CKD burden in this specific group. However,
since muscle mass is the important factor which influences creatinine, this could be a specific
problem when first diagnosing HIV or in end-stage HIV disease, as muscle mass may increase
substantially under antiretroviral treatment otherwise. This observation may also be relevant
for conditions other than HIV associated with low weight/BMI.
Agreement between creatinine based equations
Comparing the creatinine based formulae with each other the Bland Altman plot of MDRD-4
versus CKD-EPI is most conspicuous. Although both formulae are close in terms of absolute
bias and the precision is high (indicated by a low value), they show completely different behav-
ior in eGFR mean values above 90. The same pattern has been observed by other studies [47]
In moderate and severe CKD cases the MDRD-4 formula is more accurate than Cockcroft-
Gault, but it tends to underestimate kidney function in individuals with eGFR> 90 ml/min/
1.73m³ and therefore to over-diagnose CKD. [48] This issue has been addressed with the devel-
opment of the CKD-EPI formula in 2009 which remedies this over-diagnosis and keeps the
same accuracy in eGFR< 90 ml/min/1.73 m². [21] Regardless of the recent formula develop-
ment, the Cockcroft-Gault formula, introduced already in 1976, is still used quite often,
although it measures creatinine clearance and does not consider the tubular secretion, hence
overestimates GFR in general. [49] From a clinical perspective despite these differences regard-
ing prediction of clinical outcomes the Cockcroft Gault and CKD-EPI formula worked equally
well in the predominantly male Euro SIDA Cohort.[50]
Application of Black American correction factors
Considering the factor for black Americans in MDRD-4 and CKD-EPI resulted in higher esti-
mated GFR-levels in general, validated by cystatin C. This might be due to the fact, that Mala-
wian people have a different diet intake and way of living compared to most black Americans
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living in the global north. The serum creatinine levels of black Americans seem to be generally
higher than those of white American people or other ethnic groups in the US. [51,52] As we
know serum creatinine levels vary with stress, hypertension etc. which might possibly be con-
founded by stress linked to direct and indirect racial pressure in the USA, [53] however, also
epi-genetic selection among black Americans may play a role. [23–25] Our findings suggest
that this correction factor should not be used for Malawians.
This is supported by other studies which found that using eGFR formulae with the factor
for black Americans leads to an overestimation of measured GFR in South Africa, [54] as well
as in Ghana. [26] Delanaye et al. stated in their review, based on multiple findings, that
although the ethnic factor leads overall to accurately estimated GFR in black Americans, it
does not seem to be applicable in African populations. [55]
Limitations of the study
Due to the cross-sectional character of our study we obtained samples for creatinine only once.
We were unable to conduct a true gold-standard investigation. Therefore, we chose cystatin C
as a reference since it is less dependent on physiological parameters. However, cystatin C has
its own limitations and also imperfectly represents the unknown real GFR. [27] Gold-standard
measuring of GFR by inulin- or iohexol-clearance, was not possible in the outpatient and
resource-constrained study setting. Using cystatin C appeared to be an acceptable alternative.
We acknowledge that we did not use the certified reference material for cystatin C that has
been developed by the International Federation of Clinical Chemistry and Laboratory Medi-
cine (IFCC) as recommended by KDIGO in 2012. [20] This had not yet been introduced at the
university laboratory performing the analysis, however, all testsfulfilled highest quality control
standards.
Our study population is not representative of the adult general population in Malawi. Since
the study participants were enrolled from a HIV testing centre we cannot preclude selection
bias in the HIV-negative group as people who were tested HIV-negative also may have been
sicker than the general population. These differences in population characteristics could have
additionally confounded serum creatinine, resulting in biased eGFR in the HIV-negatives. Fur-
thermore, the prevalence of CKD was relatively low in our study population, allowing inference
mainly at relative high eGFR values. However, the aim of this study was not to estimate the
prevalence of CKD but to assess the performance of the different equations for eGFR which
should be less influenced by this selection.
Conclusions and Recommendations
We suggest applying the creatinine based CKD-EPI-formula without the factor for black
Americans to estimate the renal function in HIV-negative Malawian people and other similar
cohorts in SSA. We recommend caution when applying this formula in HIV-positive individu-
als, because eGFR levels are most probably overestimated. We recommend any study taking
renal function and HIV status into account to use cystatin C based equations for the HIV-posi-
tive individuals.
Since the sensitivity of creatinine-based formulae in general is low [56] especially in the
important transition from CKD stage two to three due to the hyperbolic association between
creatinine clearance and plasma creatinine, we suggest establishing a two-step testing approach,
if possible. Subjects classified in the transition stages two and three based on creatinine should
be assessed a second time according to their cystatin C levels, especially if their HIV-status is
positive. This advanced testing approach should drastically reduce misclassification, but only
slightly increase processing costs.
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Cystatin C measurement is not yet standard practice in Malawi and many other countries in
SSA because the costs are considerably higher compared to creatinine measurements. If this
remains the case, the application of a creatinine based CKD-EPI formula which corrects for
confounders such as HIV status and BMI should be aspired to. However, since muscle mass is
the important influence factor on serum creatinine, and clearly relates to BMI in underweight
individuals in absence of body fat only, the inclusion of BMI has to be done carefully. In the
long run, we highly recommend to foster the application of cystatin C based eGFR as a com-
mon standard to more accurately assess individual kidney function.
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